DNA X, Inc.
Current role
SONM
Robert Tirva
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert Tirva
DNA X, Inc. reported in an 8-K filed July 13, 2022 that Robert Tirva resigned as President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer), effective July 13, 2022. DNA X, Inc. reported in an 8-K filed July 13, 2022 that Robert Tirva resigned as President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer), effective July 13, 2022. The proxy statement of DNA X, Inc. reports total compensation of $474,811 for Robert Tirva in fiscal 2022, including a base salary of $214,103. Disclosed compensation is on record for 4 fiscal years.
“On July 13, 2022, Robert Tirva, President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer) of the Company resigned from his positions with the Company and its affiliates.”
“On July 13, 2022, Robert Tirva, President, Chief Financial Officer and Chief Operating Officer (principal financial and accounting officer) of the Company resigned from his positions with the Company and its affiliates.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
DNA X, Inc. (SONM)
SEC 8-K
Current2021-05-31–present
-
2021-05-31–2022-07-13
-
Start not stated–2022-07-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at DNA X, Inc.
Other people whose current roles at this company are on record from its filings.
- Mike Mulica CEO, Board Member
- Peter Hao Liu CEO, Board Member
- Robert Plaschke CEO
- Thomas W. Wilkinson CEO
- Jeffrey Wang Chairman, Board Member
- Michael Mulica Chairman, Board Member
- Clay Crolius CFO
- James Walker CFO
- George Thangadurai Board Member
- Jack Steenstra Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | DNA X, Inc. (SONM) | Former President, Chief Financial Officer, and Chief Operating Officer | $214,103 | $474,811 |
| 2021 | DNA X, Inc. (SONM) | Former President, Chief Financial Officer, and Chief Operating Officer | $325,000 | $924,999 |
| 2020 | DNA X, Inc. (SONM) | Chief Financial Officer | $300,000 | $921,252 |
| 2019 | DNA X, Inc. (SONM) | Chief Financial Officer | $93,269 | $472,995 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.